The counsel appearing for the UPSC told the apex court that he needs to take instructions and place on record all the aspects before any decision is taken on the issue.
The active COVID-19 cases in the country has dipped to 54,118 and comprised 0.13 per cent of the total infections, while the national COVID-19 recovery rate has further improved to 98.68 per cent, the ministry said.
The second worst hit country in terms of cases is India (42,962,953 infections and 515,036 deaths), followed by Brazil (29,056,525 infections and 652,438 deaths).
The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended giving permission for conducting a phase-3 clinical trial of the single-dose COVID-19 vaccine Sputnik Light as a booster dose.
The country has also administered over 2 crore precaution doses among the eligible beneficiaries. Additionally, over 97 per cent of India's adult population has also received their first dose of vaccine against Covid-19.
In a research note, India Ratings and Research (Ind-Ra) said it has maintained a neutral outlook for the Indian pharmaceutical sector for FY23.
The active cases comprise 0.17 per cent of the total infections, while the national COVID-19 recovery rate has further improved to 98.65 per cent, the ministry said.
The second worst hit country in terms of cases is India (42,951,556 infections and 514,589 deaths), followed by Brazil (28,978,052 infections and 651,522 deaths).
Of 19 antibodies, 17 were ineffective against the BA.2 subvariant. The researchers found that bebtelovimab, the latest monoclonal antibody to receive FDA Emergency Use Authorisation, is the only currently available antibody therapy that can adequately treat all three Omicron subvariants.
With just two days before Mahashivratri, the Odisha government has issued an important instruction regarding the celebration of the much-awaited festival dedicated to Lord Shiva.
A reduction of 22,056 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.
The US continues to be the worst-hit country with the world's highest number of cases and deaths at 78,476,869 and 935,331, according to the CSSE.
The US continues to be the worst-hit country with the world's highest number of cases and deaths at 78,036,352 and 925,438, according to the CSSE.
Based on the no-objection certificate, Biological E has initiated the clinical study in October 2021 and has evaluated the available safety and immunogenicity results of the ongoing phase 2/3 study, which indicated that the vaccine is safe and immunogenic.
More than half of those earnings will be off of its two Covid products, with the vaccine expected to bring in $32 billion in sales, and Paxlovid expected to earn $22 billion.
Copyright © 2024 - Odisha Television Limited All Rights Reserved.